Transcription of DRAFT REPORT FOR CONSULTATION: DO NOT REFERENCE - …
{{id}} {{{paragraph}}}
Example: biology
DRAFT REPORT FOR CONSULTATION: DO NOT REFERENCE - …
DRAFT REPORT FOR CONSULTATION: DO NOT REFERENCE 1 ICRP ref: 4828-8896-6249 13 June 2018 Annals of the ICRP ICRP PUBLICATION 1XX Radiological Protection in Therapy with radiopharmaceuticals Editor-in-Chief CLEMENT Associate Editor H. FUJITA Authors on behalf of ICRP PUBLISHED FOR The International Commission on Radiological Protection by [SAGE logo] Please cite this issue as ICRP, 20YY. Radiological Protection in Therapy with radiopharmaceuticals . ICRP Publication 1XX, Ann. ICRP XX (0). DRAFT REPORT FOR CONSULTATION: DO NOT REFERENCE 2 CONTENTS Editorial .. 3 ABSTRACT .. 4 PREFACE .. 5 MAIN POINTS .. 7 GLOSSARY .. 8 1. INTRODUCTION .. 12 2. RADIOPHARMACEUTICAL THERAPY METHODS: JUSTIFICATION AND OPTIMISATION .. 14 Introduction .. 14 Treatment of Hyperthyroidism and Other Benign Thyroid Conditions .. 15 Treatment of Differentiated Thyroid Cancer .. 17 Treatment of Polycythaemia Vera and Essential Thrombocythaemia .. 20 Treatment of Skeletal Metastases.
DRAFT REPORT FOR CONSULTATION: DO NOT REFERENCE 7 1 MAIN POINTS 2 Treatment with radiopharmaceuticals requires the development of administration 3 protocols that justify and optimise the treatment. Individual absorbed dose 4 estimates should be performed for treatment planning and post-administration 5 verification of doses received by tumour and normal tissues, as radiation delivered
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: